Literature DB >> 9440597

Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease.

S M Palmer1, L J Robinson, A Wang, J R Gossage, T Bashore, V F Tapson.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension associated with fibrotic occlusion of the smaller pulmonary veins. Although vasodilator therapy is effective in many patients with primary pulmonary hypertension, the role of vasodilators in PVOD is unclear because of concerns about precipitating pulmonary edema. Recently, however, there have been reports of successful therapy with oral vasodilators or intravenous administration of prostacyclin in patients with PVOD. In contrast, a patient with PVOD is described who developed acute pulmonary edema and respiratory failure during low-dose prostacyclin infusion, leading to death. This report suggests that vasodilators, especially prostacyclin, must be used with extreme caution in patients with known PVOD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9440597     DOI: 10.1378/chest.113.1.237

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  39 in total

Review 1.  Lung involvement in systemic sclerosis.

Authors:  Paul M Hassoun
Journal:  Presse Med       Date:  2010-12-30       Impact factor: 1.228

Review 2.  CT imaging of peripheral pulmonary vessel disease.

Authors:  Arnaud Resten; Sophie Maitre; Dominique Musset
Journal:  Eur Radiol       Date:  2005-05-20       Impact factor: 5.315

3.  Therapies for scleroderma-related pulmonary arterial hypertension.

Authors:  Paul M Hassoun
Journal:  Expert Rev Respir Med       Date:  2009       Impact factor: 3.772

4.  Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.

Authors:  Edward A Pankey; Matthew Epps; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  J Clin Rheumatol Musculoskelet Med       Date:  2010-12-01

5.  Pulmonary Edema Following Initiation of Parenteral Prostacyclin Therapy for Pulmonary Arterial Hypertension: A Retrospective Study.

Authors:  Nauman A Khan; Rizwan A Khan; Adriano R Tonelli; Kristin B Highland; Neal F Chaisson; Miriam Jacob; Rahul Renapurkar; Raed A Dweik; Gustavo A Heresi
Journal:  Chest       Date:  2019-02-15       Impact factor: 9.410

6.  Evaluation of pulmonary hypertension in a child: role of computed tomography.

Authors:  Saurabh Kumar Gupta; Anita Saxena; Gurpreet Singh Gulati
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

7.  Management of severe pulmonary hypertension in patients undergoing mitral valve surgery.

Authors:  Carlos D Davila; Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

8.  Nitric oxide-associated pulmonary edema in children with pulmonary venous hypertension.

Authors:  J Scott Baird; Vinod Havalad; Linda Aponte-Patel; Thyyar M Ravindranath; Tessie W October; Thomas J Starc; Arthur J Smerling
Journal:  Pediatr Cardiol       Date:  2012-10-13       Impact factor: 1.655

Review 9.  Pulmonary arterial hypertension in connective tissue diseases.

Authors:  Stephen C Mathai; Paul M Hassoun
Journal:  Heart Fail Clin       Date:  2012-07       Impact factor: 3.179

Review 10.  Pulmonary hypertension caused by sarcoidosis.

Authors:  Enrique Diaz-Guzman; Carol Farver; Joseph Parambil; Daniel A Culver
Journal:  Clin Chest Med       Date:  2008-09       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.